Proposals for managing patients with thoracic malignancies during COVID-19 pandemic - 29/11/20

Doi : 10.1016/j.resmer.2020.100769

N. Girard ^a,^⁎ , L. Greillier ^b, G. Zalcman ^c, J. Cadranel ^d, D. Moro-Sibilot ^e, J. Mazières ^f, C. Audigier-Valette ^g, J. Bennouna ^h, B. Besse ⁱ, A. Cortot ^j, S. Couraud ^k, M. Duruisseaux ^k, E. Giroux-Leprieur ^l, A.-C. Toffart ^e, V. Westeel ^m, M. Wislez ⁿ
on behalf of the
French Language Society of Pulmonology SPLF French language Oncology Group
^a Department of Medical Oncology, Institut Curie, 75005 Paris, France
^b Aix-Marseille Université, AP–HM, INSERM, CNRS, CRCM, Hôpital Nord, Multidisciplinary Oncology and Therapeutic Innovations Department, 13915 Marseille, France
^c Department of Thoracic Oncology, CIC 1425, AP–HP, Hôpital Bichat–Claude-Bernard, 75018 Paris, France
^d Department of Thoracic Oncology, AP–HP, Hôpital Tenon, 75020 Paris, France
^e Department of Pneumology, University Hospital of Grenoble, 38043 Grenoble, France
^f Department of Pneumology, University Hospital of Toulouse, 31059 Toulouse, France
^g Department of Pneumology, Hôpital Sainte-Musse, 83100 Toulon, France
^h Department of Medical Oncology, University Hospital of Nantes, 44000 Nantes, France
ⁱ Department of Medical Oncology, Institut Gustave-Roussy, 94800 Villejuif, France
^j Department of Pneumology, University Hospital of Lille, 59000 Lille, France
^k Department of Pneumology and Thoracic Oncology, University Hospital of Lyon, 69002 Lyon, France
^l Department of Thoracic Oncology, AP–HP, Hôpital Ambroise-Paré, 92100 Boulogne-Billancourt, France
^m Department of Pneumology and Thoracic Oncology, University Hospital of Besançon, INSERM UMR 1098, Université de Franche-Comté, 25000 Besançon, France
ⁿ Department of Thoracic Oncology, AP–HP, Hôpital Cochin, Inserm UMR_S 1138, Université de Paris, 75014 Paris, France

^⁎Corresponding author. Institut du Thorax Curie Montsouris, Institut Curie, 26, rue d’Ulm, 75005 Paris, France.Institut du Thorax Curie Montsouris, Institut Curie26, rue d’UlmParis75005France

connectez-vous ou créez un compte

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

The objective of this document is to formalize a degraded mode management for patients with thoracic cancers in the context of the COVID-19 pandemic. The proposals are based on those of the French High Council for Public Health, on published data outside the context of COVID-19, and on a concerted analysis of the risk-benefit ratio for our patients by a panel of experts specialized on thoracic oncology under the aegis of the French-Language Society of Pulmonology (SPLF)/French-language oncology group. These proposals are evolving (10 April 2020) according to the situations encountered, which will enrich it, and are to be adapted to our institutional organisations and to the evolution of resources during the COVID-19 epidemic. Patients with symptoms and/or COVID-19+ are not discussed in this document and are managed within the framework of specific channels.

Le texte complet de cet article est disponible en PDF.

Plan

Introduction

General considerations and measures

Patient categories

Patients with non-small cell lung cancer in the surgical phase of care

Patients with locally advanced non-small cell lung cancer undergoing chemoradiotherapy

Patients with metastatic non-small cell lung cancer

Patients with small cell lung cancer

Patients with mesothelioma

Patient with thymic malignancies

Patients in clinical trials

Disclosure of interest

Export

Vol 78

Article 100769- novembre 2020 Retour au numéro

Article précédent

Respiratory support in patients with COVID-19 (outside intensive care unit). A position paper of the Respiratory Support and Chronic Care Group of the French Society of Respiratory Diseases
C. Rabec, J. Gonzalez-Bermejo, Respiratory Support, Chronic Care Group GAVO 2 of the French Society of Respiratory Diseases SPLF, GAVO 2 collaborators, M. Mercy, L. Grassion, S. Pontier, M. Patout, R. Luque, C. Delafosse, C. Raherison-Semjen, B. Maître, L. Duthoit, A. Mendoza, L. Jacquin, J.C. Borel, P. Cervantes, J.-P. Janssens, J.-F. Chabot, C. Morelot-Panzini, D. Jaffuel

| Article suivant

Pioglitazone in pulmonary alveolar proteinosis: promising first clinical experience
C. Dupin, M. Hurtado, A. Cazes, C. Taille, M.P. Debray, C. Guenée, L. Tabeze, B. Crestani, R. Borie

Bienvenue sur EM-consulte, la référence des professionnels de santé.

connectez-vous ou créez un compte

Proposals for managing patients with thoracic malignancies during COVID-19 pandemic - 29/11/20

Abstract

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL